GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » Debt-to-Equity

Rite Aid (Rite Aid) Debt-to-Equity

: -3.35 (As of Aug. 2023)
View and export this data going back to 1970. Start your Free Trial

Rite Aid's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was $4,196 Mil. Rite Aid's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was $2,386 Mil. Rite Aid's Total Stockholders Equity for the quarter that ended in Aug. 2023 was $-1,966 Mil. Rite Aid's debt to equity for the quarter that ended in Aug. 2023 was -3.35.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Rite Aid's Debt-to-Equity or its related term are showing as below:

RADCQ' s Debt-to-Equity Range Over the Past 10 Years
Min: -733.87   Med: 7.06   Max: 97.43
Current: -3.35

During the past 13 years, the highest Debt-to-Equity Ratio of Rite Aid was 97.43. The lowest was -733.87. And the median was 7.06.

RADCQ's Debt-to-Equity is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.47 vs RADCQ: -3.35

Rite Aid Debt-to-Equity Historical Data

The historical data trend for Rite Aid's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Debt-to-Equity
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.95 9.35 10.46 59.84 -9.07

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.76 -15.36 -9.07 -6.52 -3.35

Competitive Comparison

For the Pharmaceutical Retailers subindustry, Rite Aid's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid Debt-to-Equity Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Rite Aid's Debt-to-Equity falls into.



Rite Aid Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Rite Aid's Debt to Equity Ratio for the fiscal year that ended in Feb. 2023 is calculated as

Rite Aid's Debt to Equity Ratio for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid  (OTCPK:RADCQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Rite Aid Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Rite Aid's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402